Stay updated on Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial page
- Check3 days agoChange DetectedNew related topics were added to the study record to improve classification and resource linking, including Lung cancer and MedlinePlus Genetics. These metadata updates help users discover the study under broader disease and genetics-related topics but do not change the trial details or eligibility.SummaryDifference0.2%

- Check10 days agoChange DetectedThe deletions remove the 'Lung cancer' keyword, the 'related topics' block, and the 'MedlinePlus Genetics' link from the study page. This reduces the visible disease context and related resource references on the study details page.SummaryDifference0.2%

- Check17 days agoChange DetectedLung cancer was added as a related topic tag and a related topic link to MedlinePlus Genetics was included. The site revision was updated from v3.6.4 to v3.6.5.SummaryDifference0.2%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe site revision tag was updated from v3.6.3 to v3.6.4. This signals a backend/template update without altering the study content or page structure.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page revision label changed from v3.6.2 to v3.6.3, indicating a minor update to the page version. This update does not change the displayed study information and is likely a backend tweak or small fix.SummaryDifference0.1%

- Check60 days agoChange DetectedAdds a new site revision label 'Revision: v3.6.2' to the page and removes several related topic tags ('Lung cancer', 'related topics:', 'MedlinePlus Genetics') as well as the earlier 'Revision: v3.6.0' tag. This update appears to streamline the page's metadata and navigation by updating the revision reference and pruning older or less relevant topics.SummaryDifference0.3%

Stay in the know with updates to Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial page.